In dermatofibrosarcoma protuberans (DFSP), FGF19 activates downstream signaling pathways by binding to FGFR1 and FGFR2, thereby promoting cell proliferation, survival, and migration, and ultimately driving tumor growth. The gene discussed is FGFR2; the disease is neoplasm.